Proactive Frailty Management in Primary Care: How Managed Clinical Pharmacy Delivers Results

Frailty is one of the most substantial operational and clinical pressures facing the NHS today. Across the UK, older individuals living with moderate or severe frailty account for around 40% of all hospital admissions and 60% of hospital bed days, costing UK healthcare systems an estimated £5.8 billion annually. In general practice, patients over 74 consult their GP surgery nearly four times as frequently as younger age brackets. When severe multi-morbidity and complex polypharmacy combine, primary care teams face an escalating cycle of reactive crisis intervention rather than proactive management.

Key Takeaways

• Proactive Medication Optimisation: Managing high-risk medicines, lowering anticholinergic cognitive burden, and tackling inappropriate polypharmacy significantly reduce preventable falls and hospital admissions.
• Overcoming the Rural and Coastal Deficit: Remote, fully managed clinical pharmacy provides immediate clinical capacity to practices in workforce-depleted geographic regions without burdening local GP partners with supervision.
• Measurable Cluster Impact: A dedicated clinical pharmacy service across a Welsh cluster successfully delivered over 2,100 clinical interventions in a single month, achieving a 39% reduction in inappropriate antipsychotic prescribing in dementia patients.

Why Is Frailty Becoming a Critical Challenge in Primary Care?

Frailty is a progressive condition characterised by multi-system physiological decline, leaving older individuals disproportionately vulnerable to sudden deterioration and adverse drug events. Because frailty rarely exists in isolation, it is intimately linked to polypharmacy. Two-thirds of patients over 74 live with two or more long-term conditions (requiring coordinated chronic disease management). As individual disease guidelines are applied sequentially, patients accumulate complicated regimens of ten, twelve, or more medications.

Without proactive interventions, the sheer volume of prescribed pharmaceuticals increases the likelihood of adverse drug reactions, drug-disease interactions, and non-compliance. When practices are locked into reactive episodic appointments, general practice capacity is consumed by acute flare-ups rather than the systematic, high-touch reviews required to keep frail patients stable at home.

Why Does Frailty Disproportiantely Impact Rural and Coastal Communities?

Rural and coastal communities experience a disproportionate frailty burden because their demographic profiles skew significantly older, while persistent workforce shortages reduce the local clinical capacity needed to manage complex patients. Outward migration of younger working-age people (alongside inward migration of retirees) has accelerated this age divergence over recent decades, as highlighted in the Chief Medical Officer’s Annual Report on health in an ageing society.

Consequently, a GP practice in a coastal or rural area frequently manages an older demographic cohort than their city counterparts. Attracting permanent GPs and multidisciplinary staff to isolated regions remains notoriously difficult. Traditional locum and agency supply routes only deliver fragmented cover, offering limited ongoing stability and capacity for strategic planning. For a Primary Care Network located in these rural pockets, overcoming workforce geography is essential to keeping older patients safe.

What Does Recent NHS Policy Say About Frailty?

Recent NHS policy directs primary care to shift older people’s healthcare away from reactive acute admissions and into proactive, neighbourhood-level pathways that identify vulnerability early. NHS England’s Best Practice Guide for NHS Frailty Pathways sets out what high-performing health systems must deliver, prioritising early intervention before patients reach an acute crisis.

Current guidance focuses on identifying patients at earlier tiers of vulnerability (such as Clinical Frailty Scale scores of 4 to 6) rather than intervening solely when advanced dependence occurs. The direction of travel from NHS England and the developing Neighbourhood Health models emphasises:

1. Systematic Frailty Identification: Routinely using electronic frailty indices (eFI) and clinical scoring to catch risk trajectories early.
2. Comprehensive Proactive Assessment: Transitioning from rapid episodic reviews to thorough, multidisciplinary care planning.
3. Structured Deprescribing: Systematically reducing medications with high anticholinergic burden to curb avoidable falls and acute admissions.

Meeting these national objectives requires dedicated clinical time. Practice teams cannot simply absorb complex medication reconciliations and deprescribing protocols into routine 10-minute GP consultations.

How Does a Managed Clinical Pharmacy Service Tackle Frailty?

A managed clinical pharmacy model tackles frailty by embedding senior-led, practice-integrated clinical pharmacists who assume complete operational responsibility for high-risk medication management and deprescribing without placing supervision demands on GP partners.

Rather than acting as an agency supplying unmanaged staff, a true managed pharmacy service assumes full clinical direction, control, and internal governance. Every deployed clinician is an experienced professional and qualified Independent Prescriber from day one, fully compliant with CPPE primary care training pathways.

In frailty management, clinical pharmacists conduct deep, patient-facing consultations. A formal Structured Medication Review (SMR) typically requires 30 minutes of clinical investigation. During these reviews, the pharmacist:

• Evaluates overall drug safety, checking pathology parameters and renal clearance.
• Quantifies the Anticholinergic Cognitive Burden (ACB) and curtails medicines that heighten fall risks.
• Executes safe, consensual deprescribing for medicines that offer marginal benefits.
• Directly updates clinical records, issues prescriptions, and communicates adjustments to community pharmacies, eliminating administrative spill-over onto GP desks.

Because these clinicians integrate securely into practice systems (such as EMIS Web, SystmOne, Vision, and Medicus) via remote Redcentric VPN environments, practices overcome geographical boundaries and physical estate constraints overnight.